A. Córdova et al.
4H), 2.65 (dd, J=7.2 Hz, J’=5–2 Hz, 1H), 2.49 (m, 1H), 1.52–1.40 (m,
4H), 1.30–1.20 (m, 6H), 0.92 ppm (t, J=6.8 Hz, 3H); 13C NMR
(100 MHz, CDCl3): 196.7, 166.5, 166.0, 62.1, 62.1, 42.9, 40.3, 32.0, 28.5,
21.8, 14.1, 13.9, 13.5 ppm; IR (KBr): n˜ =2964, 2936, 2874, 1731, 1466,
1447, 1369, 1295, 1223, 1201, 1146 cmÀ1; HRMS (ESI): m/z: calcd for
C13H20O5 +Na+: 279.1203 [M+Na]+; found: 279.1195; GC (chrompak
CP-Chirasil-Dex CB-column; Temperature program: 5 min,708C//28C
minÀ1//1108C, 10 min//108C minÀ1//200,10 min): tR (major enantiomer)=
40.3, tR (minor enantiomer)=40.4 min.
Cyclopropane 3c: Colorless oil; [a]2D5 =À12.8 (c=1 in CHCl3); 1H NMR
(400 MHz, CDCl3): d=9.18 (d, J=4.8 Hz, 1H), 7.40–7.10 (m, 5H), 4.35–
4.10 (m, 4H), 2.71 (td, J=7.8 Hz, J’=2.1 Hz, 2H), 2.61 (dd, J=7.2 Hz,
J’=5.1 Hz, 1H), 2.48 (m, 1H), 1.96–1.82 (m, 1H), 1.82–1.68 (m, 1H),
1.30–1.22 ppm (m, 6H); 13C NMR (100 MHz, CDCl3): 196.5, 166.3, 166.0,
140.4, 128.5, 128.5, 126.3, 62.2, 62.2, 42.8, 40.2, 34.8, 31.7, 28.5, 14.1,
14.0 ppm; IR (KBr): n˜ =2983, 1733, 1466, 1288, 1217, 697 cmÀ1; HRMS
(ESI): m/z: calcd for C18H22O5 +Na+: 341.1359 [M+Na]+; found:
341.1371; the enantiomeric excess was determined after in situ reduction
with NaBH4 of the aldehyde to the corresponding alcohol: HPLC (OD-
H column, n-hexane/iPrOH 90:10, l=250 nm, 0.5 mLminÀ1): tR (major
enantiomer)=16.9, tR (minor enantiomer)=19.6 min.
3H), 1.30–1.23 ppm (m, 6H); 13C NMR (100 MHz, CDCl3): d=196.0,
166.0, 166.5, 132.2, 122.5, 62.2, 62.2, 43.4, 39.9, 34.3, 18.0, 14.0, 13.9 ppm;
IR (KBr): n˜ =2983, 2856, 1731, 1465, 1369, 1294, 1280, 1224, 1199,
1019 cmÀ1
;
HRMS (ESI): m/z: calcd for C13H18O5 +Na+: 277.1046
[M+Na]+, found 277.1057; GC (chrompak CP-Chirasil-Dex CB-column.
Temperature program: 5 min,708C//28C minÀ1//1108C, 10 min//108C
minÀ1//200,10 min): tR (major enantiomer)=15.2, tR (minor enantio-
mer)=15.4 min.
1
Cyclopropane 3i: Colorless oil; [a]2D5 =À31.6 (c=0.6 in CHCl3); H NMR
(400 MHz, CDCl3): d=9.46 (d, J=4.7 Hz, 1H), 8.27 (d, J=8.4 Hz, 2H),
7.17 (d, J=8.4 Hz, 2H), 4.20–4.35 (m, 2H), 3.89–4.02 (m, 2H), 3.76 (d,
J=7.4 Hz, 1H), 3.33 (dd, J=4.7, 7.6 Hz, 1H), 1.29 (t, J=7.2 Hz, 3H),
0.99 ppm (t, J=7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): d= 195.7,
165.8, 164.4, 134.0, 130.8, 129.9, 128.6, 62.5, 62.2, 44.7, 38.1, 34.5, 14.0,
13.8 ppm; HRMS (ESI) m/z: calcd for C16H17ClO5 +Na+: 347.0657
[M+Na+]; found 347.0656; the enantiomeric excess was determined after
in situ reduction with NaBH4 of the aldehyde to the corresponding alco-
hol: HPLC (AD column, n-hexane/iPrOH 95:5, l=254 nm, 1 mLminÀ1):
tR (major enantiomer)=24.6, tR (minor enantiomer)=29.3 min.
1
Cyclopropane 3j: Colorless oil. [a]D =À32.9 (c=1.0 in CHCl3); H NMR
(400 MHz, CDCl3): d=9.43 (d, J=4.7 Hz, 1H), 7.15 (d, J=8.9 Hz, 2H),
6.81 (d, J=8.8 Hz, 2H), 4.34–4.21 (m, 2H), 4.00–3.90 (m, 2H), 3.85 (d,
J=1.0 Hz 1H), 3.77 (s, 3H), 3.31 (d,d, J=3.8–7.5 Hz, 1H), 1.30 (t, J=
7.1–14.3 Hz, 3H), 0.98 ppm (t, J=7.1–14.2 Hz, 3H); 13C NMR (100 MHz,
CDCl3): d=196.5, 166.4, 165.0, 159.6, 129.9, 124.3, 114.1, 62.6, 62.2, 55.5,
38.7, 35.1, 14.2, 14.0 ppm; IR (KBr): n˜ =2982, 2938, 2873, 1732, 1465,
1445, 1369, 1287, 1254, 1245, 1218, 1177, 1145, 1030 cmÀ1; HRMS (ESI)
Cyclopropane 3d: Colorless oil; [a]2D5 =À62.2 (c=1 in CHCl3); 1H NMR
(400 MHz, CDCl3): d= 9.21 (d, J=5.3 Hz, 1H) 4.11–4.28 (m, 4H), 2.59
(dd, J= 7.4, 5.2 Hz, 1H), 2.52 (m, 1H), 1.24 (q, J=7.3, 15.1 Hz, 6H),
1.20 ppm (d, J=6.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): d= 196.8,
166.5, 165.8, 62.2, 62.1, 43.2, 41.1, 26.6, 14.1, 14.0, 11.8 ppm; HRMS
(ESI): m/z: calcd for C11H16O5 +Na+: 251.0890 [M+Na]+; found:
251.0895; GC (chrompak CP-Chirasil-Dex CB-column; temperature pro-
gram: 5 min,708C//28CminÀ1//1108C, 10 min//108CminÀ1//200,10 min.): tR
(major enantiomer)=36.7, tR (minor enantiomer)=38.2 min.
m/z: calcd for [C17H20O6+Na]+: 343.1152[M+Na]+; found: 343.1165;
A
HPLC (ODH column, n-hexane/iPrOH 97:3, 0.5 mLminÀ1): tR (major en-
antiomer)=37.2, tR (minor enantiomer)=46.9 min.
Cyclopropane 3e: Colorless oil; [a]2D5 =À58.2 (c=1 in CHCl3); 1H NMR
(400 MHz, CDCl3): d= 9.54 (d, J=4.1 Hz, 1H) , 8.17 (d, J=8.6 Hz, 2H),
7.44 (d, J=8.62 Hz, 2H) , 4.23–4.38 (m, 2H), 3.91–4.05 (m, 2H), 3.85 (d,
J=7.6 Hz,1H), 3.44 (dd, J=7.6,4.1 Hz, 1H) , 1.31 (t, J=7.0 Hz, 3H),
1.01 ppm (t, J=7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3): d= 195.0,
165.3, 165.3, 147.6, 139.8, 129.6, 123.6, 62.8, 62.5, 45.0, 38.0, 34.6, 14.0,
13.8 ppm; HRMS m/z calcd for C16H17NO7 +Na+: 358.0897 [M+Na]+;
found: 358.0897; the enantiomeric excess was determined after in situ re-
duction with NaBH4 of the aldehyde to the corresponding alcohol;
HPLC (AD column, n-hexane/iPrOH 90:10, l=250 nm, 1 mLminÀ1): tR
(major enantiomer)=22.2, tR (minor enantiomer)=30.7 min.
Cyclopropane 3 f: Colorless oil; 1H NMR (400 MHz, CDCl3): d=9.40 (d,
J=4.6 Hz, 1H), 4.33–4.14 (m, 6H), 3.27 (d, J=6.7 Hz, 1H), 3.12 (dd, J=
4.5, 6.9 Hz, 1H), 1.27 ppm (m, 9H); 13C NMR (100 MHz, CDCl3): d=
194.3, 166.9, 165.0, 164.0, 63.0, 62.5, 62.1, 43.1, 38.3, 32.2, 14.0, 13.9
13.9 ppm; HRMS m/z: calcd for C13H18O7 +Na+: 309.0945 [M+Na]+;
found: 309.0954; [a]2D5 =À42.2 (c=1 in CHCl3). The enantiomeric excess
was determined after in situ reduction with NaBH4 of the aldehyde to
the corresponding alcohol. GC (chrompak CP-Chirasil-Dex CB-column,
temperature program: 1308C isocratic): tR (minor enantiomer)=14.3, tR
(major enantiomer)=14.5 min.
Cyclopropane 3g: Pale yellow oil; [a]2D5 =À55.7 (c=1.0 in CHCl3);
1H NMR (400 MHz, CDCl3): d=9.52 (d, J=4.8 Hz, 1H), 7.82–7.75 (m,
3H), 7.69 (s, 1H), 7.50–7.30 (m, 3H) 4.40–4.20 (m, 2H), 3.98 (d, J=
7.6 Hz, 1H), 3.90–3.80 (m, 2H), 3.51 (dd, J=7.6 Hz, J’=4.8 Hz, 1H),
1.32 (t, J=7.6 Hz, 3H), 0.86 ppm (t, J=7.2 Hz, 3H); 13C NMR
(100 MHz, CDCl3): d=196.1, 166.0, 164.6, 132.9, 132.8, 129.6, 128.2,
127.7, 127.6, 127.5, 126.4, 126.3, 126.3, 62.5, 62.0, 44.8, 38.3, 35.5, 14.0,
13.7 ppm; IR (KBr): n˜ = 3054, 2982, 2929, 2850, 1731, 1715, 1369, 1287,
1213, 1020, cmÀ1; HRMS (ESI): m/z: calcd for C20H20O5 +Na+: 363.1203
[M+Na]+; found: 363.1215; HPLC (ODH column, n-hexane/iPrOH=
90:10, l=250 nm, 1 mLminÀ1): tR (major enantiomer)=10.7, tR (minor
enantiomer)=29.6 min.
Cyclopropane 3h: Colorless oil; [a]2D5 =À31.4 (c=1.0 in CHCl3);
1H NMR (400 MHz, CDCl3): d=9.30 (d, J=4.8 Hz, 1H), 5.86 (ddq, J=
14.4 Hz, J’=6.8 Hz, J’’=0.8 Hz, 1H), 5.15 (ddq, J=14.4 Hz, J’=7.6 Hz,
J’’=1.6 Hz, 1H), 4.30–4.10 (m, 4H), 3.09 (dd, J=7.2 Hz, J’=7.2 Hz, 1H),
2.89 (dd, J=7.2 Hz, J’=4.8 Hz, 1H), 1.68 (dd, J=6.8 Hz, J’=1.6 Hz,
Cyclopropane 3k: Colorless oil; [a]D =À28.1 (c=1.0 in CHCl3);
1H NMR (400 MHz, CDCl3): d=9.47 (d, J=4.5 Hz, 1H), 7.30–7.22 (m,
4H), 4.34–4.23 (m, 2H), 4.01–3.94 (m, 2H), 3.77 (d, J=7.56 Hz 1H), 3.35
(d,d, J=4.3–7.4 Hz, 1H), 1.30 (t, J=7.2–14.2 Hz, 3H), 0.99 ppm (t, J=
7.1–14.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=195.8, 166.0, 164.7,
134.6, 134.5, 130.0, 129.1, 128.5, 127.0, 62.8, 62.4, 38.2, 35.0, 14.2,
14.0 ppm; IR (KBr): n˜ =2984, 2939, 2873, 1732, 1466, 1445, 1369, 1291,
1278, 1245, 1218, 1186, 1145, 1021 cmÀ1; HRMS (ESI): m/z: calcd for
C16H17ClO5 +Na+: 347.0657 [M+Na]+, found: 347.0673; the enantiomeric
excess was determined after in situ reduction of the aldehyde to the cor-
responding alcohol with NaBH4: HPLC (AD column, n-hexane/iPrOH
97:3, 1.0 mLminÀ1): tR (major enantiomer)=37.7, tR (minor enantio-
mer)=66.8 min.
Cyclopropane 3l: Colorless oil; 1H NMR (400 MHz, CDCl3): d=9.46 (d,
J=4.6 Hz, 1H), 7.42 (d, J=8.4 Hz, 2H), 7.11 (d, J=8.4 Hz, 2H), 4.35–
4.21 (m, 2H), 4.03–3.90 (m, 2H), 3.74 (d, J=7.6 Hz 1H), 3.33 (dd, J=
4.5,7.5 Hz, 1H), 1.30 (t, J=7.1 Hz, 3H), 0.99 ppm (t, J=7.0 Hz, 3H);
13C NMR (100 MHz, CDCl3): d=195.9, 166.0, 165.0, 131.8, 131.6, 130.5,
122.3, 62.8, 62.4, 38.2, 35.0, 14.2, 14.0 ppm; IR (KBr): n˜ =2982, 2937,
2873, 1735, 1466, 1445, 1369, 1288, 1278, 1245, 1218, 1181, 1145,
1011 cmÀ1; [a]D =À31.0 (c=1.0 in CHCl3); HRMS (ESI): m/z: calcd for
C16H17BrO5+Na+: 391.0152 [M+Na]+; found: 391.0145; The enantiomer-
ic excess was determined after in situ reduction of the aldehyde to the
corresponding alcohol with NaBH4: HPLC (ODH column, n-hexane/
iPrOH 97:3, 1.0 mLminÀ1): tR (major enantiomer)=41.5, tR (minor enan-
tiomer)=43.8 min.
Cyclopropane 3ab: Colorless oil; [a]D =À56.5 (c=1.0 in CHCl3);
1H NMR (400 MHz, CDCl3): d=9.40 (d, J=4.6 Hz, 1H), 7.36–7.19 (m,
13H), 6.98–6.94 (m, 2H), 5.23 (q, J=12.4–38.1 Hz, 2H), 4.84 (q, J=12.1–
26.7 Hz, 2H), 3.86 (d, J=7.6 Hz, 1H), 3.41 ppm (dd, J=4.6–7.7 Hz, 1H);
13C NMR (100 MHz, CDCl3): d=196.1, 166.1, 165.0, 135.1, 134.8, 132.2,
129.6, 129.3, 128.9, 128.8, 128.7, 128.6, 128.5, 128.4, 128.3, 68.4, 68.1, 38.6,
36.0 ppm; IR (KBr): n˜ =2955, 2924, 2850, 1728, 1498, 1455, 1378, 1286,
1278, 1215, 1217, 1179, 1142, 1029 cmÀ1; HRMS (ESI): m/z: calcd for
C26H22O5+Na+: 437.1359 [M+Na]+; found 437.1351; HPLC (ODH
column, n-hexane/iPrOH 97:3, 1.0 mLminÀ1): tR (major enantiomer)=
37.8, tR (minor enantiomer)=53.1 min.
7876
ꢀ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2008, 14, 7867 – 7879